| Code | Description | Claims | Beneficiaries | Total Paid |
| 67028 |
Intravitreal injection of a pharmacologic agent |
55,103 |
38,147 |
$8.57M |
| J9035 |
Injection, bevacizumab, 10 mg |
42,415 |
29,106 |
$2.34M |
| 92134 |
|
52,029 |
40,241 |
$2.13M |
| 67210 |
|
8,900 |
6,923 |
$1.99M |
| 67500 |
|
28,673 |
19,983 |
$1.55M |
| 92235 |
|
21,065 |
17,290 |
$1.47M |
| 67228 |
|
7,205 |
5,107 |
$1.34M |
| 92250 |
|
24,903 |
21,823 |
$1.05M |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
15,865 |
15,406 |
$892K |
| 76512 |
|
20,938 |
14,796 |
$885K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
13,571 |
13,490 |
$613K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
17,450 |
12,182 |
$303K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
4,272 |
4,252 |
$220K |
| J7999 |
Compounded drug, not otherwise classified |
11,312 |
8,222 |
$199K |
| 92242 |
|
1,212 |
1,118 |
$185K |
| 92226 |
|
4,708 |
2,464 |
$94K |
| 92201 |
|
7,089 |
5,868 |
$93K |
| 67145 |
|
304 |
257 |
$64K |
| 92083 |
|
2,095 |
1,472 |
$39K |
| 92133 |
|
1,482 |
1,476 |
$33K |
| 92225 |
|
623 |
329 |
$20K |
| 67113 |
|
15 |
14 |
$10K |
| 92287 |
|
223 |
174 |
$8K |
| J3300 |
Injection, triamcinolone acetonide, preservative free, 1 mg |
105 |
76 |
$7K |
| 67220 |
|
13 |
12 |
$4K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
40 |
40 |
$920.41 |
| 92020 |
|
50 |
26 |
$716.71 |
| 92202 |
|
15 |
13 |
$269.23 |